I now have thorough textbook data to compose a complete, well-organized answer.
Complications During ATT for Abdominal TB and Their Management
Complications fall into two broad groups: (A) Drug-related adverse effects from ATT itself, and (B) Disease-related complications from the TB infection during or after treatment.
A. Drug-Related Complications
1. Hepatotoxicity (Most Common Serious Adverse Effect)
Causative drugs: INH > PZA > RIF (all three can cause liver injury)
| Situation | Action |
|---|
| Asymptomatic ALT rise (mild) | Continue ATT; increase monitoring frequency |
| ALT >5x ULN (any symptoms) OR >3x ULN with symptoms | Stop all hepatotoxic drugs immediately |
| Bilirubin + ALP disproportionately high | Suspect RIF-specific hepatotoxicity |
"Drug-induced hepatitis is the most frequent serious adverse reaction to first-line drugs. An asymptomatic increase in ALT may be observed in nearly 20% of patients..." - Murray & Nadel's Respiratory Medicine
Management steps:
- Stop ATT; rule out other causes (viral hepatitis, alcohol, biliary disease)
- If patient is seriously ill/infectious: start a liver-sparing bridge regimen: Ethambutol + Levofloxacin + Aminoglycoside (streptomycin/amikacin)
- Monitor ALT until it falls to <2x ULN, then restart sequentially:
- RIF first (least hepatotoxic) ± EMB → wait 3-7 days
- Then restart INH
- If ALT remains stable: restart PZA (most hepatotoxic - omit if prior severe reaction)
- If PZA cannot be restarted: extend total ATT duration to 9 months (2HRE + 7HR)
Risk factors for ATT hepatotoxicity: Age >60, female sex, HIV, chronic liver disease (hepatitis B/C), alcohol use, Asian ethnicity, slow NAT2 acetylator genotype.
2. Peripheral Neuropathy (INH)
Mechanism: INH competitively inhibits pyridoxine (Vitamin B6), causing functional B6 deficiency
Incidence: ~2% at standard doses (5 mg/kg/day); rises to >17% at higher doses
High-risk groups: Diabetics, HIV patients, malnourished patients, alcoholics, CKD, elderly, pregnant/breastfeeding women
Management:
- Prevention (mandatory in high-risk): Pyridoxine 25-50 mg/day with each INH dose
- Some experts give pyridoxine to ALL patients on INH
- If neuropathy develops despite pyridoxine: increase dose to 100 mg/day
- If refractory: consider dose reduction or cessation of INH
Seizures from INH toxicity (rare, usually overdose):
- Hospitalize immediately
- IV pyridoxine (gram-for-gram if INH dose unknown) + antiepileptics (benzodiazepines)
3. Optic Neuritis (Ethambutol)
Presentation: Reduced visual acuity, central scotoma, loss of green-red color discrimination
Incidence: ~19/1000 patients at doses ≤27.5 mg/kg/day; dose-dependent
Management:
- Baseline visual acuity (Snellen) + color discrimination before starting EMB; repeat monthly
- Stop EMB immediately if any visual symptoms develop
- Refer to ophthalmologist promptly
- Recovery takes ~3 months on average but can be permanent if delayed
- Children too young to report visual changes: weigh risk-benefit carefully
4. Hyperuricemia and Gout (Pyrazinamide)
Mechanism: PZA inhibits renal uric acid excretion
Management:
- Asymptomatic hyperuricemia: No treatment needed; monitor
- Symptomatic gout: Allopurinol (xanthine oxidase inhibitor) or other urate-lowering therapy
- Avoid aspirin (interferes with uric acid handling); use NSAIDs with caution
- PZA is contraindicated in acute gout
- Note: Ethambutol can also cause mild hyperuricemia
5. GI Symptoms (Nausea, Vomiting, Abdominal Pain)
Causative drugs: All first-line drugs, especially PZA and EMB
- Important: First rule out hepatotoxicity by checking ALT/bilirubin before attributing to simple GI intolerance
Management:
- Take medications at bedtime to minimize symptoms
- Take with a light low-fat snack
- Antacids or proton pump inhibitors (PPIs)
- Antiemetics 30 min before ATT: ondansetron, metoclopramide, or promethazine
6. Skin Rash / Hypersensitivity
All four first-line drugs can cause rashes.
| Rash type | Drug | Management |
|---|
| Simple pruritic rash, no systemic signs | Any | Antihistamines ± topical corticosteroids; continue ATT |
| Photosensitivity | PZA | Avoid sun, use sunscreen; can persist weeks after stopping PZA |
| Petechial rash / thrombocytopenia | RIF | Stop RIF; replace with rifabutin once platelets recover |
| Mucous membrane involvement / fever | Any | Suspect Stevens-Johnson syndrome - stop all ATT; dermatology + TB specialist consult |
| Rash + eosinophilia + lymphadenitis + organ involvement | Any | Suspect DRESS syndrome - stop all ATT immediately; specialist consult |
Reintroduction after rash: Restart drugs sequentially at 2-3 day intervals; if rash recurs, stop the last drug added.
7. Rifampicin-Specific: Important Drug Interactions
RIF is a potent inducer of CYP450 enzymes - a critical concern in abdominal TB patients on other drugs:
- Oral contraceptives: Reduced efficacy - advise barrier contraception
- Antiretrovirals (HIV co-infection): Major interaction with protease inhibitors/NNRTIs - use rifabutin instead, or specialist-guided regimen
- Warfarin: Reduced anticoagulant effect - monitor INR closely, dose-adjust
- Corticosteroids: Reduced steroid effect - may need to increase steroid dose (relevant when using adjunctive steroids for peritoneal TB)
- Orange discoloration of urine, tears, saliva, skin - warn patients; harmless but distressing
B. Disease-Related Complications (During/After ATT)
8. Intestinal Obstruction from Strictures
This is the most important disease complication specific to abdominal TB. Strictures can:
- Pre-exist before ATT begins
- Paradoxically develop or worsen in the first 2-3 months after starting ATT (due to fibrosis during healing)
Management (elective):
- After completing medical treatment, re-image the small bowel (barium follow-through or CT enterography)
- Persistent symptomatic strictures → surgical options:
- Strictureplasty (single short stricture)
- Limited ileocolic resection + anastomosis (ileocaecal hyperplastic disease)
- Right hemicolectomy (extensive ileocolic disease)
- "Surgical principles are similar to Crohn's disease - resections should be kept as conservative as possible." - Bailey & Love's Surgery, 28th Ed.
Management (emergency - acute obstruction):
- Vigorous IV resuscitation (correct dehydration, electrolytes, anemia)
- Laparotomy: minimum life-saving procedure
- Resection of obstructed segment + proximal ileostomy + distal mucus fistula (anastomosis avoided in acute infection - high leak risk)
- Primary anastomosis only if the patient's general condition permits
- Continue full 6-month ATT course post-operatively under combined physician-surgical care
9. Bowel Perforation
- Rare; from a perforated tuberculous ulcer in the small bowel
- Presents as acute peritonitis
- Requires emergency laparotomy, resection, and peritoneal lavage
- ATT continued post-operatively
10. Paradoxical Reactions (Immune Reconstitution)
Definition: Temporary clinical or radiographic worsening despite appropriate ATT and good adherence - due to restored immune response attacking TB antigens
In abdominal TB: May manifest as:
- Worsening abdominal pain or ascites
- Enlarging mesenteric lymph nodes
- New or worsening bowel obstruction symptoms
In HIV co-infected patients on ART: Known as Immune Reconstitution Inflammatory Syndrome (IRIS) - presents with fever, lymphadenopathy, expanding lesions
Management:
- Rule out treatment failure and drug resistance first
- Continue ATT (do NOT stop)
- Corticosteroids (prednisolone 1-2 mg/kg/day) for severe paradoxical reactions, tapered over 4-8 weeks
- For IRIS: continue both ATT and ART; add steroids for severe cases
Summary Table
| Complication | Causative Drug | Key Management |
|---|
| Hepatotoxicity | INH, PZA, RIF | Stop if ALT >5x ULN; restart sequentially (RIF → INH → PZA) |
| Peripheral neuropathy | INH | Pyridoxine 25-50 mg/day (prevent); 100 mg/day (treat) |
| Optic neuritis | EMB | Monthly visual monitoring; stop EMB immediately if symptoms |
| Hyperuricemia/gout | PZA | Allopurinol for symptomatic gout; monitor uric acid |
| GI intolerance | All (esp. PZA) | Bedtime dosing, light snack, PPIs, antiemetics |
| Rash/hypersensitivity | All | Antihistamines (mild); stop all ATT (SJS/DRESS) |
| CYP450 drug interactions | RIF | Adjust warfarin, OCP, ART doses accordingly |
| Intestinal obstruction | Disease (stricture) | Strictureplasty / resection (elective); ileostomy (emergency) |
| Paradoxical reaction | Immune response | Continue ATT; add steroids for severe cases |
| Perforation | Disease | Emergency surgery + continue ATT |
Sources: Murray & Nadel's Textbook of Respiratory Medicine | Bailey & Love's Short Practice of Surgery, 28th Ed. | Katzung's Basic & Clinical Pharmacology, 16th Ed. | Lippincott Illustrated Reviews: Pharmacology | Harrison's Principles of Internal Medicine, 22nd Ed.